Atlas Trials

Metastatic Pancreas Adenocarcinoma

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Pancreas Adenocarcinoma

RecordFirmDate
Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer (NCT02620800)Celgene2016-01-18
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma (NCT07573215)Revolution Medicines, Inc.

Track Metastatic Pancreas Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.